MedTrace Logo

remedē System Therapy Study

NCT03884660 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 225

Last updated 2025-07-24

No results posted yet for this study

Summary

The purpose of this non-randomized post market study is to collect clinical data on the safety and effectiveness of the remedē System in a real-world setting.

Conditions

  • Central Sleep Apnea

Interventions

DEVICE

remede System

Patients undergoing a remede System implant attempt. Study devices will be used per approved indications for use for each geography.

Sponsors & Collaborators

  • Respicardia, Inc.

    lead INDUSTRY

Principal Investigators

  • Kathy McPherson · ZOLL Respicardia, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-18
Primary Completion
2026-06-30
Completion
2030-12-30
FDA Device
Yes

Countries

  • United States
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03884660 on ClinicalTrials.gov